Hyperproinsulinemia segregates young adult patients with newly diagnosed autoimmune (type 1) and non‐autoimmune (type 2) diabetes

By Bolinder J.   Fernlund P.   Borg H.   Arnqvist H. J.   Björk E.   Blohmé G.   Eriksson J. W.   Nyström L.   Östman J.   Sundkvist G.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 65, Iss. 7, 2005-11 ,pp. : 585-594

Informa Healthcare

Access to resources Recommend Favorite

Effects of early use of pioglitazone in combination with metformin in patients with newly diagnosed type 2 diabetes

By Chalmers J.   Hunter J. E.   Robertson S. J.   Baird J.   Martin M.   Franks C. I.   Whately-Smith C. R.   Mariz S.   Campbell I. W.  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1775-1781

Informa Healthcare

Access to resources Recommend Favorite

Initiating therapy in patients newly diagnosed with type 2 diabetes: Combination therapy vs a stepwise approach

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. : 497-507

John Wiley & Sons Inc

Access to resources Recommend Favorite

‘25‐Hydroxyvitamin D, Autoantigenic and Total Antibody Concentrations: Results from a Danish Case–control Study of Newly Diagnosed Patients with Childhood Type 1 Diabetes and their Healthy Siblings’

By  

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (ELECTRONIC), Vol. 87, Iss. 1, 2018-01 ,pp. : 46-53

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of glycemic control on the Diabetes Complications Severity Index score and development of complications in people with newly diagnosed type 2 diabetes

By  

JOURNAL OF DIABETES, Vol. 10, Iss. 3, 2018-03 ,pp. : 192-199

John Wiley & Sons Inc

Access to resources Recommend Favorite